Evaluating EHR Data Availability for Cohort Selection in Retrospective Studies

Proceedings - 2016 IEEE International Conference on Healthcare Informatics, ICHI 2016

Volumn , Issue , 2016, Pages 380-387

  Harrell, Morgan ^a   Fabbri, Daniel ^a   Levy, Mia ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; HOSPITAL DATA PROCESSING; INFORMATION SCIENCE; PATIENT TREATMENT;

CLINICAL TRIAL; DATA AVAILABILITY; DATA UTILITIES; ELECTRONIC HEALTH RECORD SYSTEMS; ENDOCRINE THERAPY; HEALTH-CARE SYSTEM; PATIENT POPULATION; VANDERBILT UNIVERSITY;

DIAGNOSIS;

EID: 85010297270     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ICHI.2016.68     Document Type: Conference Paper

References (15)

1. P. M. Nadkarni, "Drug safety surveillance using de-identified EMR and claims data: issues and challenges." Journal of the American Medical Informatics Association : JAMIA, vol. 17, no. 6, pp. 671-4, 2010
2. "The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction." vol. 2, no. 9, p. e840, 2007.
3. J.-F. Diaz-Garelli, E. V. Bernstam, Mse, M. H. Rahbar, and T. Johnson, "Rediscovering drug side effects: the impact of analytical assumptions on the detection of associations in EHR data." AMIA Joint Summits on Translational Science proceedings AMIA Summit on Translational Science, vol. 2015, pp. 51-5, 2015.
4. L. Li, C. Shen, X. Li, and J. M. Robins, "On weighting approaches for missing data." Statistical methods in medical research, vol. 22, no. 1, pp. 14-30, 2013.
5. J. Zhao, "Temporal weighting of clinical events in electronic health records for pharmacovigilance, " in 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2015, pp. 375-381.
6. B. J. Wells, K. M. Chagin, A. S. Nowacki, and M. W. Kattan, "Strategies for handling missing data in electronic health record derived data." EGEMS (Washington, DC), vol. 1, no. 3, p. 1035, 2013.
7. D. M. Roden, J. M. Pulley, M. A. Basford, G. R. Bernard, E. W. Clayton, J. R. Balser, and D. R. Masys, "Development of a large-scale de-identified DNA biobank to enable personalized medicine." Clinical pharmacology and therapeutics, vol. 84, no. 3, pp. 362-9, 2008.
8. H. Xu, S. P. Stenner, S. Doan, K. B. Johnson, L. R. Waitman, and J. C. Denny, "MedEx: a medication information extraction system for clinical narratives." Journal of the American Medical Informatics Association : JAMIA, vol. 17, no. 1, pp. 19-24, 2010.
9. N. authors listed, "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, " Lancet, vol. 365, no. 9472, pp. 1687-1717, 2005.
10. D. L. Hershman, "Perfecting breast-cancer treatment-incremental gains and musculoskeletal pains." The New England journal of medicine, vol. 372, no. 5, pp. 477-8, 2015.
11. A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett, J. F. Forbes, G. Hoctin-Boes, J. Houghton, G. Y. Locker, and J. S. Tobias, "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer." Lancet, vol. 365, no. 9453, pp. 60-2, 2005.
12. T. L. Lash, M. P. Fox, J. L. Westrup, A. K. Fink, and R. A. Silliman, "Adherence to tamoxifen over the five-year course." Breast cancer research and treatment, vol. 99, no. 2, pp. 215-20, 2006.
13. D. L. Hershman, T. Shao, L. H. Kushi, D. Buono, W. Y. Tsai, L. Fehrenbacher, M. Kwan, S. L. Gomez, and A. I. Neugut, "Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer." Breast cancer research and treatment, vol. 126, no. 2, pp. 529-37, 2011.
14. "Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group." vol. 351, no. 9114, pp. 1451-67, 1998.
15. S. Masood, "Estrogen and progesterone receptors in cytology: A comprehensive review, " Diagnostic Cytopathology, vol. 8, no. 5, pp. 475-491, 1992.